PURECLEANSE Trademark

Trademark Overview

On Friday, September 22, 2017, a trademark application was filed for PURECLEANSE with the United States Patent and Trademark Office. The USPTO has given the PURECLEANSE trademark a serial number of 79220097. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, January 31, 2025. This trademark is owned by Australian Biotechnologies Pty Limited. The PURECLEANSE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Product development in the field of allograft processes; quality control for others in the field of human biological products in the nature of allografts; laboratory analysis of allograft tissues; scientific research, technology research and new product design services relating to allograft processing techniques; scientific research for medical purposes in the field of allografts; medical research in the biotechnology field; engineering in the medical and biotechnology fields; product research and development in the field of allograft surgery
purecleanse

General Information

Serial Number79220097
Word MarkPURECLEANSE
Filing DateFriday, September 22, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, January 31, 2025
Registration Number5516222
Registration DateTuesday, July 17, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2018

Trademark Statements

Pseudo MarkPURE CLEANSE
Goods and ServicesProduct development in the field of allograft processes; quality control for others in the field of human biological products in the nature of allografts; laboratory analysis of allograft tissues; scientific research, technology research and new product design services relating to allograft processing techniques; scientific research for medical purposes in the field of allografts; medical research in the biotechnology field; engineering in the medical and biotechnology fields; product research and development in the field of allograft surgery

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 31, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAustralian Biotechnologies Pty Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU
Party NameAustralian Biotechnologies Pty Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU
Party NameAustralian Biotechnologies Pty Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Tuesday, November 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 2, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, November 11, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, December 27, 2017ASSIGNED TO EXAMINER
Friday, December 29, 2017NON-FINAL ACTION WRITTEN
Saturday, December 30, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, January 13, 2018REFUSAL PROCESSED BY MPU
Saturday, January 13, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, February 3, 2018REFUSAL PROCESSED BY IB
Wednesday, March 14, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 14, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 15, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 22, 2018ASSIGNED TO LIE
Wednesday, April 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 1, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 1, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 17, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, October 17, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, November 1, 2018FINAL DISPOSITION PROCESSED
Thursday, November 1, 2018FINAL DISPOSITION NOTICE SENT TO IB
Saturday, November 24, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, June 25, 2022NEW REPRESENTATIVE AT IB RECEIVED
Sunday, March 12, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 17, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, July 24, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, August 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 7, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 31, 2025CANCELLED SECTION 71

Related Keywords

purecleanse research field allograft product medical biotechnology scientific development allografts relating